BOWNU icon

Bowen Acquisition Corp Unit
BOWNU

1 day
0.00%
5 days
0.00%
1 month
0.00%
3 months
0.00%
6 months
0.00%
Year to date
0.00%
1 year
0.00%
5 years
0.00%
10 years
0.00%
 

About: Bowen Acquisition Corp is a blank check company.

Financials Shell Companies
0
Funds holding %
of 7,252 funds
–
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0% more ownership

Funds ownership: 0.09% [Q4 2024] → 0.1% (+0%) [Q1 2025]

38% less capital invested

Capital invested by funds: $95.6K [Q4 2024] → $59.3K (-$36.3K) [Q1 2025]

50% less funds holding

Funds holding: 2 [Q4 2024] → 1 (-1) [Q1 2025]

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for BOWNU.

See Analyst Rankings

Financial journalist opinion

Neutral
GlobeNewsWire
1 year ago
Bowen Acquisition Corp Announces Entering into Merger Agreement with Shenzhen Qianzhi BioTech Company
New York, NY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bowen Acquisition Corp (NASDAQ: BOWN) (“BOWN”), a special purpose acquisition company, announced the execution of an agreement and plan of merger (the “Merger Agreement”) with Shenzhen Qianzhi BioTechnology Co., Ltd (“Qianzhi BioTech”), a biotech company engaged in development, manufacturing and sales of ozonated health and wellness products in China.
Bowen Acquisition Corp Announces Entering into Merger Agreement with Shenzhen Qianzhi BioTech Company
See News Rankings
Charts implemented using Lightweight Charts™